Literature DB >> 3411639

Effect of helicopter transport of trauma victims on survival in an urban trauma center.

W R Schiller1, R Knox, H Zinnecker, M Jeevanandam, M Sayre, J Burke, D H Young.   

Abstract

This paper reports a retrospective analysis of patients with serious yet substantially survivable injuries represented by ISS scores from 20 to 39 and whether or not survival was influenced by the use of helicopters. A review of 606 of these patients with blunt trauma was performed for the period from 1983 through 1986. When the group was evaluated there were 451 patients in the ISS cohort of 20-29 and 155 in the 30-39 group. The mean age was 30.5 years and 76% were males. A total of 259 patients were transported by ambulance and 347 by helicopter. Characteristics of the two groups were similar. The mean TS was 12.7 for ambulance and 12.1 for helicopter patients. Mean GCS was 10.4 in the ambulance group and 9.6 for helicopter patients. Overall the mortality for ambulance transported patients was 13% compared to 18% for the helicopter group. We conclude that there is no survival advantage in the helicopter transported group in an urban area with a sophisticated prehospital care system. Patients of rural origin deserve further study.

Entities:  

Mesh:

Year:  1988        PMID: 3411639     DOI: 10.1097/00005373-198808000-00004

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  21 in total

Review 1.  Accident and emergency medicine--I.

Authors:  R C Evans; R J Evans
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

2.  [Deployment and efficacy of ground versus helicopter emergency service for severely injured patients. Analysis of a nationwide Swiss trauma center].

Authors:  S Günkel; M König; R Albrecht; M Brüesch; R Lefering; K Sprengel; C M L Werner; H-P Simmen; G A Wanner
Journal:  Unfallchirurg       Date:  2015-03       Impact factor: 1.000

3.  [The influence of transportation mode on mortality in polytraumatized patients. An analysis based on the German Trauma Registry].

Authors:  M Frink; C Probst; F Hildebrand; M Richter; C Hausmanninger; B Wiese; C Krettek; H-C Pape
Journal:  Unfallchirurg       Date:  2007-04       Impact factor: 1.000

4.  Investigation of final destination hospitals for patients in helicopter emergency medical services (doctor-helicopter) in Fukushima Prefecture.

Authors:  Choichiro Tase; Yuko Ohno; Arifumi Hasegawa; Yasuhiko Tsukada; Jiro Shimada; Yukihiro Ikegami
Journal:  J Anesth       Date:  2010-04-06       Impact factor: 2.078

5.  Europe and the tropics.

Authors:  S Mukhopadhyay
Journal:  J R Soc Med       Date:  1993-11       Impact factor: 5.344

6.  Utilization of the helicopter emergency medical service.

Authors:  M McKee
Journal:  J R Soc Med       Date:  1993-11       Impact factor: 5.344

7.  External validation of the Air Medical Prehospital Triage score for identifying trauma patients likely to benefit from scene helicopter transport.

Authors:  Joshua B Brown; Mark L Gestring; Francis X Guyette; Matthew R Rosengart; Nicole A Stassen; Raquel M Forsythe; Timothy R Billiar; Andrew B Peitzman; Jason L Sperry
Journal:  J Trauma Acute Care Surg       Date:  2017-02       Impact factor: 3.313

8.  Cost-effectiveness of helicopter versus ground emergency medical services for trauma scene transport in the United States.

Authors:  M Kit Delgado; Kristan L Staudenmayer; N Ewen Wang; David A Spain; Sharada Weir; Douglas K Owens; Jeremy D Goldhaber-Fiebert
Journal:  Ann Emerg Med       Date:  2013-04-09       Impact factor: 5.721

9.  Retrospective review of injury severity, interventions and outcomes among helicopter and nonhelicopter transport patients at a Level 1 urban trauma centre.

Authors:  R Scott Hannay; Amy D Wyrzykowski; Chad G Ball; Kevin Laupland; David V Feliciano
Journal:  Can J Surg       Date:  2014-02       Impact factor: 2.089

10.  Prehospital helicopter transport and survival of patients with traumatic brain injury.

Authors:  Kimon Bekelis; Symeon Missios; Todd A Mackenzie
Journal:  Ann Surg       Date:  2015-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.